Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis

Clinical trial NCT00838214 · COMPLETED

Trial details

NCT number: NCT00838214
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Autoimmune Hepatitis

Start date: 2001-03-01
Primary completion: 2008-12-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.